Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
about
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug actionCirculating monocytes from healthy individuals and COPD patientsAssociation of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokersCXCR2: a target for pancreatic cancer treatment?Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a reviewAutonomous protein sample processing on-chip using solid-phase microextraction, capillary force pumping, and microdispensing.Alveolar macrophage recruitment and activation by chronic second hand smoke exposure in mice.Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation.Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease.The role of the CCR1 receptor in the inflammatory response to tobacco smoke in a mouse modelRole of th17 cell and autoimmunity in chronic obstructive pulmonary disease.Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium.Inhibition of granulocyte migration by tiotropium bromideThe standardized herbal formula, PM014, ameliorated cigarette smoke-induced lung inflammation in a murine model of chronic obstructive pulmonary disease.Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma.Chemokine expression by small sputum macrophages in COPD.Potential new drugs for therapy of chronic obstructive pulmonary disease.Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse modelAirway inflammation and hypersensitivity induced by chronic smoking.Chronic obstructive pulmonary disease * 12: New treatments for COPDPhage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cellsThe effects of corticosteroids on COPD lung macrophages: a pooled analysisRoflumilast inhibits the release of chemokines and TNF-α from human lung macrophages stimulated with lipopolysaccharide.Bronchoabsorption; a novel bronchoscopic technique to improve biomarker sampling of the airway.Myeloid-specific Fos-related antigen-1 regulates cigarette smoke-induced lung inflammation, not emphysema, in miceRole of macrophage chemoattractant protein-1 in acute inflammation after lung contusionRandomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lungRole of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposureInverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functionsCOPD exacerbations . 2: aetiologyOutcome measures for COPD treatments: a critical evaluation.Alveolar macrophages as orchestrators of COPD.Pulmonary emphysema: when more is less.
P2860
Q24595639-72360123-925D-4F69-8062-EC1F2DC25357Q24805326-E12BA11B-DE43-4C67-9538-B9EAC5FED45AQ24810037-7030E6A1-F891-47FE-9B5D-330A9EE5F84CQ27021588-714C4C78-CDAD-4159-B5A9-68E8B9F8924AQ28390078-1D60E62D-D51D-4C57-B963-69837B3256BBQ31132308-77CB4BDE-29BF-4CF5-8C9B-B59A32C8D97DQ33866072-4C915287-E9D5-4ABF-929A-8ED8A4B626FFQ34036043-1079D914-36AC-4A25-9404-B2E3E6C71E58Q34053650-56CE9D84-3A2B-429A-85CC-57A724ED1C69Q34065620-9F897023-F287-4A3E-8FAE-982101C06BB0Q34106030-8F3208A4-A0F6-4F0A-BCCC-A99EA6A8D74AQ34127425-0D768F99-9183-4892-9151-61B4E2834710Q34145804-1F092D93-2B1A-4D06-979A-1DE29E5017FAQ34274539-CC83F6C0-6830-4B8B-B033-4A3D468A7D75Q34598796-92FA2EF3-D17E-4C18-A4D0-7539D6B63F2BQ34638204-9666EC4A-6844-45E8-A0DE-30FA339744FFQ34980255-68E3510A-262E-4073-8339-A6A46DC1A577Q34997388-13CD0BD3-DBD7-4A9C-866D-C2EA1A613A65Q35136709-9826D03C-8B00-4D17-B475-9F01CC9CC1F6Q35164728-8B51B402-BC9C-41DF-B3B8-89700EBEC342Q35191277-E22FDDFD-556B-43C7-BC90-FA257C914B2DQ35204615-B8E603FB-E03E-4AC4-92D1-DE05A4C426DAQ35208742-16C6860C-A017-43E0-BEC3-2519ACDA10A1Q35498810-F24C4760-4E1D-4277-9557-3C873A899321Q35557425-E9B13849-994A-4FC2-8C43-F3B7CB540727Q35834390-87970CA4-0D30-47F7-B008-85C077AD8193Q35985973-2B40F965-5BF6-4E88-A302-37C6C10C8347Q36025380-EFCC6F3C-1CD9-4717-BD1E-25501678A3EEQ36027413-1357A591-4625-4068-B9FF-9890275460E6Q36049462-7F117E9F-79D1-4890-9FB2-C4EC32E093ACQ36049758-7AE7A522-503A-4E24-8CAE-826A6AE100B3Q36093531-EA59944E-5128-4315-9640-E202F04C826CQ36110564-8B4EAA12-5E76-47A7-877F-F0C5D11D9FDBQ36120008-F1174227-75DE-4959-BE42-9802539ABBA1Q36376519-3B7D7F8F-D34F-47AD-BD3F-0C4BDF4DF8F2Q36410084-07E733E7-049D-45B3-ADD2-8A1E808C004FQ36414253-F948816A-4176-403E-97EF-C5444CA721FEQ36602287-E66E484D-562A-47F1-A3DD-368177B53DF9Q36602291-94801F99-E1E3-4564-8CD4-F58C0155A4FBQ36659971-D3F61299-2B4C-48A0-A92A-A308A21A6C6A
P2860
Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increased levels of the chemok ...... mples from patients with COPD.
@ast
Increased levels of the chemok ...... mples from patients with COPD.
@en
type
label
Increased levels of the chemok ...... mples from patients with COPD.
@ast
Increased levels of the chemok ...... mples from patients with COPD.
@en
prefLabel
Increased levels of the chemok ...... mples from patients with COPD.
@ast
Increased levels of the chemok ...... mples from patients with COPD.
@en
P2093
P2860
P921
P356
P1433
P1476
Increased levels of the chemok ...... amples from patients with COPD
@en
P2093
P J Barnes
S L Traves
S V Culpitt
P2860
P304
P356
10.1136/THORAX.57.7.590
P407
P577
2002-07-01T00:00:00Z